Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2017-04-06 | Mr. Bradway has been our President since May 2010 and Chief Executive Officer since May 2012. |
| Filing Date | Source Excerpt |
|---|---|
| 2018-03-16 | Mr. Bradway brings to the Board critical skills in the areas of high technology, product development, financial oversight, and risk management. His experience as a senior executive in the biotechnology industry, including as Chief Executive Officer, Chief Operating Officer, and Chief Financial Officer of Amgen, provides him with an extensive understanding of the strategic considerations and challenges associated with a complex, highly regulated industry. In recognition of Mr. Bradway’s experience in corporate finance, risk management, and executive leadership, the Board elected him to serve on the Audit and Finance Committees. 2017 Director Compensation Table: Robert A. Bradway total compensation $409,675. |
| 2019-03-15 | Mr. Bradway brings to the Board critical skills in the areas of high technology, product development, financial oversight, and risk management. His experience as a senior executive in the biotechnology industry, including as Chief Executive Officer, Chief Operating Officer, and Chief Financial Officer of Amgen, provide him with an extensive understanding of the strategic considerations and challenges associated with a complex, highly regulated industry. In recognition of Mr. Bradway's experience in corporate finance, risk management, and executive leadership, the Board elected him to serve on the Audit and Finance Committees. 2018 Director Compensation Table: Robert A. Bradway total $346,000. |
| 2020-03-13 | Mr. Bradway brings to the Board critical skills in the areas of high technology, product development, financial oversight, product safety, and risk management. His experience as a senior executive in the biotechnology industry, including as Chief Executive Officer, Chief Operating Officer, and Chief Financial Officer of Amgen, provides him with an extensive understanding of the strategic considerations and challenges associated with meeting the requirements of numerous safety and regulatory compliance regimes around the world. In addition, he previously served as a director of Norfolk Southern Corporation, one of the nations largest railroad transportation companies, where virtually every aspect of operations is heavily regulated and subject to strict safety-related oversight. In recognition of Mr. Bradways experience in corporate finance, risk management, and executive leadership, the Board elected him to serve on the Audit and Finance Committees. |
| 2021-03-05 | Mr. Bradway brings to the Board critical skills in the areas of high technology, product development, financial oversight, product safety, and risk management. His experience as a senior executive in the biotechnology industry, including as Chief Executive Officer, Chief Operating Officer, and Chief Financial Officer of Amgen, provides him with an extensive understanding of the strategic considerations and challenges associated with meeting the requirements of numerous safety and regulatory compliance regimes around the world. In addition, he previously served as a director of Norfolk Southern Corporation, one of the nations largest railroad transportation companies, where virtually every aspect of operations is heavily regulated and subject to strict safety-related oversight. In recognition of Mr. Bradways experience in corporate finance, risk management, and executive leadership, the Board elected him to serve on the Audit and Finance Committees. |
| 2022-03-11 | Mr. Bradway brings to the Board critical skills in the areas of high technology, product development, financial oversight, product safety, and risk management. His experience as a senior executive in the biotechnology industry, including as Chief Executive Officer, Chief Operating Officer, and Chief Financial Officer of Amgen, provides him with an extensive understanding of the strategic considerations and challenges associated with meeting the requirements of numerous safety and regulatory compliance regimes around the world. In addition, he previously served as a director of Norfolk Southern Corporation, one of the nations largest railroad transportation companies, where virtually every aspect of operations is heavily regulated and subject to strict safety-related oversight. In recognition of Mr. Bradways experience in corporate finance, risk management, and executive leadership, the Board elected him to serve as Chair of the Finance Committee. |
| 2023-03-03 | Mr. Bradway serves as Chair of the Finance Committee and is a member of the Governance & Public Policy Committee. He is an independent director, age 60. 2022 Director Compensation Table shows total compensation of $386,000. |
| 2024-04-05 | Robert A. Bradway Boeing director since: 2016 Committees: Finance (Chair), Governance & Public Policy Independent: Yes Age: 61 2023 Director Compensation Table: Fees Earned or Paid in Cash: $155,000, Stock Awards: $200,000, All Other Compensation: $31,089, Total: $386,089 |
| 2025-03-07 | Chairman & CEO, Amgen |
Data sourced from SEC filings. Last updated: 2025-07-01